Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.4000 (13.27%) ($6.4000 - $6.4000) on Thu. Jan. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.16% (three month average) | RSI | 71 | Latest Price | $6.4000(13.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 20.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) CEMB(79%) TLT(61%) EMHY(57%) FXI(54%) MCHI(53%) | Factors Impacting CAPR price | CAPR will decline at least -3.58% in a week (0% probabilities). XRT(-16%) TBT(-34%) UUP(-22%) USO(-6%) VXX(-23%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.58% (StdDev 7.16%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $6.37(0.47%) | 10 Day Moving Average | $5.8(10.34%) | 20 Day Moving Average | $4.95(29.29%) | To recent high | -17% | To recent low | 21.9% | Market Cap | $126m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |